Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05170113 · ClinicalTrials.gov registry record · NA
Evaluate the Effectiveness and Safety of the Alpinia Galanga Formulation, Theacrine Formulation, and Caffeine Formulation on Fatigue, Mental Acuity, and Cognitive Health
A NA study of Fatigue, sponsored by Supplement Formulators.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
- 1
- Study location
NCT05170113: Completed NA study of Fatigue, sponsored by Supplement Formulators.
NCT05170113 is a NA study of Fatigue that has completed, run by Supplement Formulators. The registered enrollment target is 79 participants, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05170113, a NA study of Fatigue, has completed, sponsored by Supplement Formulators.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the effectiveness and safety of the Alpinia galanga formulation, Theacrine formulation, and Caffeine formulation on fatigue, mental acuity, and cognitive health among overall healthy participants
Primary Outcome
Assessment of the mean change in the results of the VAS-F survey from baseline. This consists of 18 items relating to the subjective experience of fatigue with a Fatigue subscale and Energy subscale. The scores can range from 0-10 and the lower the score indicates a better outcome.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Alpinia galanga formulation
- DIETARY_SUPPLEMENT Theacrine formulation
- DIETARY_SUPPLEMENT Caffeine formulation
Study Locations (1)
Florida
- Life Extension Clinical Research - Fort Lauderdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2021-11-02 |
| Est. Completion | 2022-05-31 |
| Phase | NA |
What the finished NCT05170113 record still lists
NCT05170113 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Fatigue appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT05170113 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05170113 about?
NCT05170113 is a clinical study titled "Evaluate the Effectiveness and Safety of the Alpinia Galanga Formulation, Theacrine Formulation, and Caffeine Formulation on Fatigue, Mental Acuity, and Cognitive Health". The purpose of this study is to assess the effectiveness and safety of the Alpinia galanga formulation, Theacrine formulation, and Caffeine formulation on fatigue, mental acuity, and cognitive health among overall healthy participants
What is the current status of trial NCT05170113?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2021-11-02. Estimated completion is 2022-05-31.
What conditions does trial NCT05170113 study?
This clinical trial studies the following conditions: Fatigue.
What interventions are being tested in trial NCT05170113?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Alpinia galanga formulation (DIETARY_SUPPLEMENT), Theacrine formulation (DIETARY_SUPPLEMENT), Caffeine formulation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05170113?
This trial is sponsored by Supplement Formulators, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05170113 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fatigue
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05170113's enrollment target sits among peer trials
79 48th of 109 higher than 62 of 109 other Fatigue trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fatigue trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fatigue and Cognitive Demand With Aging
RECRUITING · NA
-
Behavioral and Neural Correlates of Post-Stroke Fatigue
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
-
The Fit With Us Study
RECRUITING · NA
-
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
RECRUITING · NA
-
Lifting More Than Weights: Resistance Exercise Program Across Socioeconomic Groups for Cancer-Related Fatigue Management
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI